title: Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients.
abstract: OBJECTIVE
  To evaluate the prognostic value of lactate clearance and lactate production in severely ill septic patients with normal or mildly elevated blood lactate concentration. DESIGN Prospective, observational study.
  
  
  METHODS
  Nineteen-bed mixed medicosurgical intensive care unit.
  
  
  METHODS
  Fifty-six patients with severe sepsis and blood lactate concentration <3 mmol/L.
  
  
  RESULTS
  Lactate metabolism was evaluated in all patients. Lactate clearance was measured by modeling the change in arterial blood lactate over time induced by an infusion of 1 mmol/kg sodium lactate for 15 mins. Lactate production was calculated as the product of lactate clearance times the blood lactate concentration before the infusion. Outcome was taken to be mortality at 28 days after the beginning of the septic episode. A logistic regression model taking into account different risk factors was constructed. Among the 56 patients, 17 (30.3%) died before the 28th day. Basal blood lactate concentration was not different between survivors and nonsurvivors, whereas lactate clearance and production were higher in survivors (0.86 +/- 0.32 vs. 0.58 +/- 0.18 L/hr/kg, p < .005, and 1.19 +/- 0.63 vs. 0.89 +/- 0.24 mmol/hr/kg, p = .055, respectively). An increase in blood lactate 45 mins after the end of the lactate infusion (Deltalact-T60) > or = 0.6 mmol/L was predictive of 28-day mortality with 53% sensitivity and 90% specificity. Multivariate analysis showed that only three factors were independently and significantly correlated with 28-day mortality: presence of more than two organ failures (odds ratio, 27; p = .04), age >70 yrs (odds ratio, 5.7; p = .032), and Deltalact-T60 > or =0.6 mmol/L (odds ratio, 14.2; p = .042).
  
  
  CONCLUSIONS
  Low lactate clearance in severely ill septic patients with normal or mildly elevated blood lactate is predictive of poor outcome independently of other known risk factors such as age and number of organ failures.
authors.affiliation: Département d'Anesthésie-Réanimation Est, Hôpital Saint-Roch, Nice, France.
authors.forename: Jacques
authors.initials: J
authors.lastname: Levraut
authors.forename: Carole
authors.initials: C
authors.lastname: Ichai
authors.forename: Isabelle
authors.initials: I
authors.lastname: Petit
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Ciebiera
authors.forename: Olivier
authors.initials: O
authors.lastname: Perus
authors.forename: Dominique
authors.initials: D
authors.lastname: Grimaud
mesh_terms: D017677:Age Distribution; D000367:Age Factors; D000368:Aged; D001784:Blood Gas Analysis; D015897:Comorbidity; D016638:Critical Illness; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D007262:Infusions, Intravenous; D019344:Lactic Acid / Q000008:administration & dosage / Q000378:metabolism*; D016015:Logistic Models; D008297:Male; D008657:Metabolic Clearance Rate; D009102:Multiple Organ Failure / Q000382:microbiology; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D011517:Prothrombin Time; D012372:ROC Curve; D012307:Risk Factors; D018805:Sepsis / Q000150:complications / Q000378:metabolism* / Q000401:mortality*; D012720:Severity of Illness Index; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D019344:Lactic Acid